RxDoctor Payments Data

Dale Thomae, DO

Internal Medicine · Ashland, OHNPI 1922087741

Payments from drug & device makers

$4,288in general payments, 2019–2025

Across 380 payments — averaging $11.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
  • Johnson & Johnson$490
  • Ardelyx, Inc.$228
  • Phathom Pharmaceuticals, Inc.$203
  • Regeneron Healthcare Solutions, Inc.$160
  • plus $537 from 13 others

What the payments were for

  • Food & beverage$4,10696%
  • Education$1824%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,288 in reported general payments places this provider in the 85th percentile of 4,428 internal medicine providers in Ohio.

See all internal medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$87,410
Medicare patients
393
Services billed
819

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
StelaraUstekinumab11$300,708
Humira(Cf) PenAdalimumab23$159,061
CreonLipase/Protease/Amylase41$81,650
LinzessLinaclotide46$37,371
IbsrelaTenapanor Hcl15$26,138
TrulancePlecanatide38$21,043
ViberziEluxadoline14$17,555
MovantikNaloxegol Oxalate17$13,999
Mesalamine28$9,397
Dexlansoprazole DrDexlansoprazole14$5,679
Pantoprazole Sodium445$5,190
Budesonide DrBudesonide26$3,629
NexiumEsomeprazole Magnesium14$3,449
ShingrixVaricella-Zoster Ge/As01b/Pf16$3,019
Colestipol Hcl41$2,065

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonStelara$490$300,70811 claims
AbbVieCreon, Linzess, Viberzi$1,336$136,576101 claims
Ardelyx, Inc.Ibsrela$228$26,13815 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance$1,333$21,04338 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,428 internal medicine providers in Ohio.

Other internal medicine in Ashland

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →